Inflammation's role in a heart disease that can cause sudden death.
Arrhythmogenic Cardiomyopathy is an Inflammatory Disease
This study is looking at how inflammation affects arrhythmogenic cardiomyopathy, a heart condition that can be especially risky for young athletes, and it aims to find out if exercise makes it worse and whether anti-inflammatory treatments can help keep hearts safer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10629180 on NIH RePORTER |
What this research studies
This research investigates how inflammation contributes to arrhythmogenic cardiomyopathy (ACM), a serious heart condition that can lead to sudden death, particularly in young athletes. The study aims to understand how exercise exacerbates this condition by activating inflammatory pathways in heart cells. Researchers will use advanced genetic techniques in mouse models to explore the mechanisms behind this disease and test whether anti-inflammatory treatments can mitigate its effects. The findings could lead to new strategies for preventing dangerous heart events in affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with arrhythmogenic cardiomyopathy, especially those who are young and physically active.
Not a fit: Patients with arrhythmogenic cardiomyopathy who are not physically active or do not have significant inflammatory responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to targeted therapies that significantly reduce the risk of sudden cardiac events in patients with arrhythmogenic cardiomyopathy.
How similar studies have performed: Previous research has shown promising results in understanding the role of inflammation in heart diseases, suggesting that this approach could lead to meaningful advancements.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Saffitz, Jeffrey E — Beth Israel Deaconess Medical Center
- Study coordinator: Saffitz, Jeffrey E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.